Balyasny Asset Management LLC Simulations Plus, Inc. Transaction History

Balyasny Asset Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$34.96 - $43.94 $197,244 - $247,909	-5,642 Reduced 46.62%	6,460 $283,000
Q4 2022 Feb 14, 2023	SELL	$36.55 - $51.15 $4,422 - $6,189	-121 Reduced 0.99%	12,102 $442,000
Q3 2022 Nov 14, 2022	BUY	$47.75 - $66.88 $95,452 - $133,693	1,999 Added 19.55%	12,223 $593,000
Q2 2022 Aug 15, 2022	BUY	$40.55 - $51.76 $186,570 - $238,147	4,601 Added 81.82%	10,224 $504,000
Q1 2022 May 16, 2022	SELL	$36.56 - $50.98 $262,573 - $366,138	-7,182 Reduced 56.09%	5,623 $287,000
Q4 2021 Feb 14, 2022	SELL	$37.1 - $57.45 $2,819 - $4,366	-76 Reduced 0.59%	12,805 $606,000
Q3 2021 Nov 15, 2021	BUY	$38.45 - $55.66 $192,749 - $279,023	5,013 Added 63.71%	12,881 $509,000
Q2 2021 Aug 16, 2021	BUY	$49.67 - $68.96 $134,258 - $186,398	2,703 Added 52.33%	7,868 $432,000
Q1 2021 May 17, 2021	BUY	$60.06 - $89.52 $310,209 - $462,370	5,165 New	5,165 $327,000
Q3 2020 Nov 16, 2020	SELL	$57.51 - $75.36 $419,880 - $550,203	-7,301 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$32.91 - $59.82 $240,275 - $436,745	7,301 New	7,301 $437,000

176

15.2M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $636M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.